Atracurium besilate Injection 25 mg/2.5 mL vial أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

atracurium besilate injection 25 mg/2.5 ml vial

hospira australia pty ltd - atracurium besilate, quantity: 10 mg/ml - injection - excipient ingredients: water for injections; benzenesulfonic acid - atracurium besylate is indicated as an adjunct to general anesthesia, to facilitate endotrachael intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation.

Atracurium Besylate Injection USP (ATRAVITA) كينيا - الإنجليزية - Pharmacy and Poisons Board

atracurium besylate injection usp (atravita)

reddys pharma limited off mombasa road, masai road nairobi - atracurium besilate bp - injection - atracurium besilate bp 10mg/ml - atracurium

Cisatracurium APOTEX cisatracurium (as besilate) 5 mg / 2.5 mL solution for injection ampoule أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

cisatracurium apotex cisatracurium (as besilate) 5 mg / 2.5 ml solution for injection ampoule

arrotex pharmaceuticals pty ltd - cisatracurium besilate, quantity: 2.68 mg/ml (equivalent: cisatracurium, qty 2 mg/ml) - injection, solution - excipient ingredients: water for injections; benzenesulfonic acid - cisatracurium injection is indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit.

Cisatracurium APOTEX cisatracurium (as besilate) 10 mg / 5 mL solution for injection ampoule أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

cisatracurium apotex cisatracurium (as besilate) 10 mg / 5 ml solution for injection ampoule

arrotex pharmaceuticals pty ltd - cisatracurium besilate, quantity: 2.68 mg/ml (equivalent: cisatracurium, qty 2 mg/ml) - injection, solution - excipient ingredients: water for injections; benzenesulfonic acid - cisatracurium injection is indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit.

Cisatracurium APOTEX cisatracurium (as besilate) 20 mg / 10 mL solution for injection ampoule أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

cisatracurium apotex cisatracurium (as besilate) 20 mg / 10 ml solution for injection ampoule

arrotex pharmaceuticals pty ltd - cisatracurium besilate, quantity: 2.68 mg/ml - injection, solution - excipient ingredients: water for injections; benzenesulfonic acid - cisatracurium injection is indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit.

Hospira Atracurium Besilate 10 mg/mL Injection 250 mg/25 mL vial أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

hospira atracurium besilate 10 mg/ml injection 250 mg/25 ml vial

hospira australia pty ltd - atracurium besilate, quantity: 10 mg/ml - injection, solution - excipient ingredients: water for injections; benzenesulfonic acid - atracurium besilate injection is indicated as an adjunct to general anaesthesia during surgery to relax skeletal muscles, and to facilitate endotracheal intubation and mechanical ventilation. it is also indicated to facilitate mechanical ventilation in intensive care unit (icu) patients.

Cisatracurium-AFT نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

cisatracurium-aft

aft pharmaceuticals ltd - cisatracurium besilate 0.268%{relative} equivalent to cisatracurium 0.2% w/v - solution for injection - 2 mg/ml - active: cisatracurium besilate 0.268%{relative} equivalent to cisatracurium 0.2% w/v excipient: benzenesulfonic acid water for injection - cisatracurium-aft is indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit.

Cisatracurium-AFT نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

cisatracurium-aft

aft pharmaceuticals ltd - cisatracurium besilate 0.669%{relative} equivalent to cisatracurium 0.5% w/v - solution for injection - 5 mg/ml - active: cisatracurium besilate 0.669%{relative} equivalent to cisatracurium 0.5% w/v excipient: benzenesulfonic acid water for injection - cisatracurium-aft is indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit.

Atracurium Besilate 10mg/ml Solution for Injection مالطا - الإنجليزية - Medicines Authority

atracurium besilate 10mg/ml solution for injection

hospira uk limited horizon, honey lane, hurley, maidenhead sl6 6rj, united kingdom - atracurium besilate - solution for injection - atracurium besilate 10 milligram(s)/millilitre - muscle relaxants

Atracurium besilate Solution for Injection 10 mg/ml مالطا - الإنجليزية - Medicines Authority

atracurium besilate solution for injection 10 mg/ml

jv healthcare limited navi buidlings, pantar road, lija, lja 2021, malta - atracurium besilate - solution for injection - atracurium besilate 10 milligram(s)/millilitre - muscle relaxants